IC50

Overview

IC50 (half-maximal inhibitory concentration) is the concentration of an inhibitor required to reduce a specific biological or biochemical function by 50% under defined experimental conditions. It is one of the most widely reported quantitative measures of a compound's inhibitory potency and is used extensively in pharmacology, biochemistry, and drug discovery to compare the relative effectiveness of different inhibitors.

A lower IC50 value indicates that less compound is needed to achieve 50% inhibition, signifying greater potency. IC50 values are typically expressed in molar concentrations (nM, uM) and are derived from dose-response curves generated under standardized assay conditions.

Detailed Explanation

Determination

IC50 is determined experimentally by exposing a biological system (enzyme, cell culture, receptor preparation) to a range of inhibitor concentrations and measuring the resulting activity at each concentration. The data are plotted as a sigmoidal dose-response curve — percent activity (or percent inhibition) versus log concentration — and the IC50 is the concentration corresponding to 50% inhibition.

The mathematical model most commonly used to fit the data is the four-parameter logistic (Hill) equation:

Response = Bottom + (Top - Bottom) / (1 + (Concentration / IC50)^n)

Where n is the Hill coefficient describing the slope of the curve.

Context Dependency

A critical distinction between IC50 and intrinsic binding constants (such as Ki) is that IC50 values are assay-dependent. The measured IC50 for a given inhibitor can vary based on:

• Substrate concentration — For competitive inhibitors, increasing substrate concentration raises the apparent IC50
• Incubation time — Slow-binding or irreversible inhibitors may show different IC50 values at different time points
• Assay conditions — Temperature, pH, buffer composition, and protein concentration all influence the result
• Cell type — In cell-based assays, receptor density and downstream signaling machinery affect the IC50

For this reason, IC50 values from different laboratories or different assay systems should be compared with caution.

IC50 vs. Ki

The inhibition constant (Ki) is a more fundamental measure of inhibitor-receptor interaction that is independent of assay conditions. The relationship between IC50 and Ki depends on the mechanism of inhibition and the assay conditions. For competitive inhibitors, the Cheng-Prusoff equation relates the two:

Ki = IC50 / (1 + [S] / Km)

Where [S] is the substrate concentration and Km is the Michaelis constant.

Selectivity Assessment

Comparing IC50 values across different targets is a standard method for assessing selectivity. A compound with an IC50 of 10 nM at its target receptor and 10,000 nM at an off-target receptor demonstrates 1,000-fold selectivity, suggesting a favorable therapeutic window.

Relevance to Peptide Research

IC50 is a fundamental metric in peptide research for several applications:

Protease Inhibitor Characterization — Many research peptides function as protease inhibitors, and their IC50 values against specific proteases define their inhibitory potency. Peptide-based inhibitors of angiotensin-converting enzyme (ACE), dipeptidyl peptidase-4 (DPP-4), and matrix metalloproteinases (MMPs) are characterized by their IC50 profiles.

Receptor Binding Competition — In competitive binding assays, the IC50 of a peptide reflects its ability to displace a labeled ligand from a receptor. This is used to compare the relative affinity of different peptide analogs for a given receptor target.

Structure-Activity Relationships — During peptide analog development, systematic modification of the peptide sequence and measurement of resulting IC50 changes allows researchers to identify which residues are critical for inhibitory activity and to optimize potency.

Examples

The peptide-based DPP-4 inhibitor diprotin A has an IC50 of approximately 6.7 uM against DPP-4. In contrast, the synthetic drug sitagliptin has an IC50 of approximately 18 nM — roughly 370-fold more potent. This comparison illustrates how IC50 enables direct quantitative comparison of inhibitory potency across structurally diverse compounds.

In receptor binding studies, different GLP-1 receptor agonist peptides can be ranked by their IC50 values in competition assays, with lower values indicating tighter binding and typically correlating with greater biological activity.

Related Terms

IC50 is the inhibitory counterpart to EC50, which measures the concentration producing 50% of the maximal activating effect. Both are measures of potency and are distinct from efficacy, which describes the maximum achievable effect. IC50 values are related to affinity through the Cheng-Prusoff equation and are used alongside selectivity ratios to characterize compound profiles.